Evoke Pharma, Inc.

EVOK
$47.05 (+ $0.00 + 0.00%)
Last updated: 2026-06-30 16:12 UTC
EVOK Metrics
Exchange
🇬🇧 LSE XLON
London Stock ExchangeUnited KingdomEurope/London
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS30049G1040
CUSIP30049G104
Market Price47.05
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.38
Market Cap$18.9M
Book Value1.56
Price to Book7.056
Beta-0.14
52w High11.0
52w Low1.94
Next Earnings DateN/A

Evoke Pharma, Inc. trades under ticker EVOK on LSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US30049G1040, CUSIP 30049G104.

About the Company
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.
Price History